Transformation of cancer diagnostics with artificial intelligence
DoMore Diagnostics is a pioneer in utilizing artificial intelligence to increase the prognostic and predictive value of cancer tissue biopsies.
DoMore Diagnostics is based in Oslo, Norway and is headed by the CEO and Co-founder Torbjørn Furuseth.
DoMore Diagnostics joined NOME in 2022.